Implantable Medical System Alternate Electrode Therapy Vector

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Implantable medical systems face challenges in sustaining therapy delivery due to lead-related conditions such as insulation breaches, conductor fractures, and intermittent contacts, which can lead to short or open circuits, impairing cardiac activity sensing and reducing the effectiveness of pacing or defibrillation therapy.

Innovation Solution

The implementation of an implantable medical system with a lead having a first electrode and an alternate electrode, which switches therapy delivery from the first electrode to the alternate electrode in response to a lead-related condition, and an oversense reduction module that reconfigures therapy and sensing functions to maintain effective therapy delivery through the alternate electrode.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If lead-related conditions occur (insulation breaches, conductor fractures), then therapy delivery is impaired, but adding alternate electrodes increases device complexity

Engineering Contradiction:
Improvetherapy delivery reliabilityVSAvoidlead system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent incorporates alternate electrodes and backup conductors into the lead system during manufacturing, before any lead-related conditions occur. This preliminary preparation ensures that when insulation breaches or fractures happen, the system can immediately switch to pre-configured alternate therapy vectors without requiring complex real-time decision-making or additional components.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent designs the lead system with redundant electrodes and conductors that serve as pre-prepared backup pathways. When a lead-related condition compromises the primary therapy delivery path, the system has already-positioned alternate vectors ready to compensate, cushioning against therapy delivery failure without increasing operational complexity.

Inventive Principle:
Principle #11Beforehand cushioning (Prior cushioning)

2Duration of action of stationary object

If therapy switches to alternate electrode, then therapy continuity is maintained, but sensing accuracy may be compromised due to oversensing

Engineering Contradiction:
Improvetherapy delivery continuityVSAvoidsensing accuracy
Core Design Contradiction:
Duration of action of stationary objectVSMeasurement precision

Solution Approach 1:

The patent extracts and removes oversensing artifacts from the electrical signals detected by the alternate electrode. The device identifies and eliminates spurious signals that do not represent true cardiac activity, allowing accurate sensing to continue even when using alternate therapy vectors following a lead-related condition.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces signal processing algorithms and filtering mechanisms as intermediaries between the alternate electrode and the sensing system. These intermediaries process the raw electrical signals, removing oversensing artifacts while preserving genuine cardiac electrical activity, thereby maintaining sensing accuracy despite the switch to alternate vectors.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS9974964B2Fault tolerant implantable medical system
Publication Date: 2018.05.22 MEDTRONIC INC
  • US9974964B2 patent drawing
  • US9974964B2 patent drawing
  • US9974964B2 patent drawing

AI summary

The disclosure describes implantable medical systems that respond to occurrence of a lead-related condition by utilizing an elongated coil electrode in defining an alternative pacing therapy vector to maintain optimal drain of an IMD power supply. An exemplary system includes a medical electrical lead having an elongated electrode and an improved sensing and therapy delivery circuitry to provide the alternative pacing therapy vector responsive to the lead-related conditions. The system reconfigures the operation of the sensing and therapy delivery circuitry triggered by the switch to the alternative pacing therapy vector.